IPO Boutique Research, Color & More Information for Subscribers
This content is restricted to IPO Boutique Subscribers Username or Email Password Remember me Lost your password? Become a Subscriber Disclaimer IPO Boutique aggregates information on public companies and private companies, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry[…]
IPO BOUTIQUE CLIENTS and IPO BOUTIQUE SECONDARY ALERTS CLIENTS received ALL this information to their inbox on a REAL TIME basis. If having real-time alerts for secondary offerings would be an advantage to you, inquire about a subscription today! Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis.[…]
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Viking Therapeutics, Inc. Symbol: VKTX Price: Last trade $1.46 Trade Date: 4/6 Shares: 6.2 million Underwriter(s) Maxim Group, FBR Rating=Subscription Needed[…]
This past week four IPOs debuted, eleven updated terms and two new deals filed. It was tough sledding for the four deals that debuted. The strongest deal of the week, BluePrint Medicines Corporation (Nasdaq: BPMC), upsized and priced ($18.00) above range. ‘BPMC’ opened 30-percent higher with a $23.40 tick at first trade. However, BluePrint traded[…]
This past week seven IPOs debuted, three updated terms and two new deals filed. It was one of the strongest weeks for the IPO market this year as seven deals came to market with two of them producing gains of more than 100% just minutes after opening. Aduro Biotech (Nasdaq: ADRO), after upsizing and pricing[…]